Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03382938
NA

Dexmedetomidine Wound Infiltration in Cesarean Section

Sponsor: Attikon Hospital

View on ClinicalTrials.gov

Summary

The effects of four different wound infiltration protocols in cesarean section will be investigated on parturient' pain intensity, PCA morphine consumption given, side effects and parturient' overall satisfaction. One group will receive for wound infiltration dexmedetomidine, the second ropivacaine, the third dexmedetomidine combined with ropivacaine, while the last one will receive normal saline (placebo group).

Official title: Wound Infiltration With Dexmedetomidine in Cesarean Section: Effect on Postoperative Analgesia

Key Details

Gender

FEMALE

Age Range

18 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2019-08-23

Completion Date

2026-11-20

Last Updated

2025-03-19

Healthy Volunteers

No

Interventions

DRUG

Dexmedetomidine

WOUND INFILTRATION IN CESAREAN SECTION

DRUG

Ropivacaine

WOUND INFILTRATION IN CESAREAN SECTION

DRUG

Dexmedetomidine - Ropivacaine

WOUND INFILTRATION IN CESAREAN SECTION

OTHER

0,9% saline

placebo WOUND INFILTRATION IN CESAREAN SECTION

Locations (1)

Paraskevi K Matsota

Athens, Other, Greece